相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
Dongli Cai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
B7-H4, a promising target for immunotherapy
Jia-Yu Wang et al.
CELLULAR IMMUNOLOGY (2020)
TISIDB: an integrated repository portal for tumor-immune system interactions
Beibei Ru et al.
BIOINFORMATICS (2019)
Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
Shanjuan Hong et al.
PROTEIN & CELL (2019)
Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer
Heather L. MacGregor et al.
ONCOIMMUNOLOGY (2019)
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
Ling Wang et al.
CANCER CELL INTERNATIONAL (2018)
Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
Gregory M. Chen et al.
CLINICAL CANCER RESEARCH (2018)
Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T Cells
Jing Li et al.
IMMUNITY (2018)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Ming Yi et al.
MOLECULAR CANCER (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis
Yun Ye et al.
MEDICINE (2018)
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature
Stella Capriglione et al.
MEDICAL ONCOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
B7-H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence
Fu-Biao Kang et al.
ONCOTARGET (2017)
B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation
Xinran Chen et al.
CANCER SCIENCE (2016)
B7-H4 expression in ovarian serous carcinoma: a study of 306 cases
Li Liang et al.
HUMAN PATHOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F. McDermott et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro
Hsin-I Hung et al.
SCIENTIFIC REPORTS (2016)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line
Hai-xia Peng et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Wei-Ting Hwang et al.
GYNECOLOGIC ONCOLOGY (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
Xiaojie Wang et al.
PLOS ONE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response
Dagmar Quandt et al.
CLINICAL CANCER RESEARCH (2011)
The B7 family of immunoregulatory receptors: A comparative and evolutionary perspective
John D. Hansen et al.
MOLECULAR IMMUNOLOGY (2009)
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma
Ilona Kryczek et al.
CANCER RESEARCH (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
B7-H3 and B7-H4 expression in non-small-cell lung cancer
Yuping Sun et al.
LUNG CANCER (2006)
B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival
Amy E. Krambeck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
I Kryczek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
B7-H4 is highly expressed in ductal and lobular breast cancer
B Tringler et al.
CLINICAL CANCER RESEARCH (2005)
Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family
IH Choi et al.
JOURNAL OF IMMUNOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
